ANTIBODIES THAT BIND TO CEACAM5

PE0016062026A1Pending Publication Date: 2026-08-17F HOFFMANN LA ROCHE & CO AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: PE2026001903
Authority / Receiving Office: PE · PE
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-12-18
Filing Date: 2024-12-18
Publication Date: 2026-08-17

Application Information

Patent Timeline

18 Dec 2024

Priority

18 Dec 2024

Application

PE2026001903

17 Aug 2026

Publication

PE0016062026A1

IPC: C07K16/28; A61K39/00; C07K16/30

CPC: C07K16/2803; C07K2317/92; A61K2039/505; C07K16/3007; C07K2317/24; C07K2317/567; C07K2317/31; C07K16/2809

Inventors: BUJOTZEK Alexander Christian; FERRARA KOLLER Claudia

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to an antibody that binds to CEACAM5, to an isolated polynucleotide encoding the antibody, to a host cell comprising the isolated polynucleotide, and to a method for producing said antibody. The invention also relates to a pharmaceutical composition comprising the antibody and a pharmaceutically acceptable carrier. The antibody or the pharmaceutical composition enables the treatment of a disease such as cancer.

Need to check novelty before this filing date? Find Prior Art